EUVIMEDEUVIMED entdecken
Crossref

Arecoline hydrobromide suppresses PI3K/AKT pathway in rheumatoid arthritis synovial fibroblasts and relieves collagen-induced arthritis in mice

Jiaxin He, Xian Lin, Xiaocheng Wang, Tengyu Lin, Shuyan Lyu, Xu Gao, Jian Chen, Qingwen Wang

International Immunopharmacology · 2023

DOI: 10.1016/j.intimp.2023.110925 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Jiaxin He und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatism and Immunology, Peking University Shenzhen Hospital, Shenzhen 518036, China; Institute of Immunology and Inflammatory Diseas…. Hauptthemen laut MEDLINE: Arthritis, Experimental, Arthritis, Rheumatoid, Synoviocytes. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, Science, Technology and Innovation Commission of Shenzhen Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: This study investigated the effectiveness of arecoline hydrobromide (AH) on the functions of rheumatoid arthritis fibroblast-like synoviocytes (RA-FLSs) and collagen-induced arthritis (CIA) mice. METHODS: Immunofluorescence was used to identify RA-FLSs. Cell Counting Kit-8 (CCK-8) was used to determine the viability of RA-FLSs and the half maximal inhibitory concentration (IC50) of AH. The 5-ethynyl-2'-deoxyuridine (EdU) assay was used to detect DNA replication in RA-FLSs. Cell cycle and apoptosis were examined by flow cytometry. Migration and invasion, as well as wound healing assays, were employed to determine cell migration and invasion ability. Proteins and mRNA expression levels were investigated using Western blot, quantitative real-time PCR (RT-qPCR), and immunofluorescence. The CIA mice model was used to assess the effect of AH in vivo. RNA-sequencing (RNA-seq) was used to find the potential signaling pathways of AH against RA, and Western blot was used to verify the key signaling pathway of AH on RA-FLSs. Network pharmacology and molecular docking were used to predict drug targets. RESULTS: AH inhibited the proliferation and DNA replication of RA-FLSs, promoted cell cycle arrest by reducing the levels of cyclin-dependent kinase 1 (CDK1), cyclin A2, and cyclin B1, promoted apoptosis by suppressing B-cell lymphoma-2 (Bcl-2) expression, and suppressed migration and invasion by inhibiting vimentin expression in RA-FLSs. AH was also effective in relieving arthritis in vivo. RNA sequencing analyses suggested that AH inhibited the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT) pathway in RA-FLSs, which was also confirmed in Western blot analysis. Furthermore, network pharmacology and molecular docking suggested that F2, MAPK14, SRC, AKT1, and CTSK might be the direct targets of AH. CONCLUSION: AH can modulate the pathological process of RA-FLSs by blocking the PI3K/AKT pathway and relieve CIA in mice, making it a potential new small molecule candidate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, ExperimentalArthritis, RheumatoidSynoviocytesAnimalsMiceProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasePhosphatidylinositol 3-KinasesMolecular Docking SimulationCell ProliferationFibroblastsCells, CulturedArecoline

Stichwörter der Autor:innen

Arecoline hydrobromidePI3K/AKTRA-FLSsRheumatoid arthritis

Substanzen

Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasePhosphatidylinositol 3-Kinasesarecoline hydrobromideArecoline

Autor:innen und Institutionen

  • Department of Rheumatism and Immunology, Peking University Shenzhen Hospital, Shenzhen 518036, China; Institute of Immunology and Inflammatory Diseases, Shenzhen Peking University-The Hong Kong University of Science and…
  • Institute of Immunology and Inflammatory Diseases, Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen 518036, China. Electronic address: shuylv@163.com.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong Province
  • Science, Technology and Innovation Commission of Shenzhen Municipality
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

He, J., Lin, X., Wang, X., Lin, T., Lyu, S., Gao, X., Chen, J., & Wang, Q. (2023). Arecoline hydrobromide suppresses PI3K/AKT pathway in rheumatoid arthritis synovial fibroblasts and relieves collagen-induced arthritis in mice. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110925

Vancouver

He J, Lin X, Wang X, Lin T, Lyu S, Gao X, et al. Arecoline hydrobromide suppresses PI3K/AKT pathway in rheumatoid arthritis synovial fibroblasts and relieves collagen-induced arthritis in mice. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110925

BibTeX
@article{He2023,
  author = {He, Jiaxin and Lin, Xian and Wang, Xiaocheng and Lin, Tengyu and Lyu, Shuyan and Gao, Xu and Chen, Jian and Wang, Qingwen},
  title = {Arecoline hydrobromide suppresses PI3K/AKT pathway in rheumatoid arthritis synovial fibroblasts and relieves collagen-induced arthritis in mice},
  journal = {International Immunopharmacology},
  year = {2023},
  doi = {10.1016/j.intimp.2023.110925}
}
Kostenlos starten →